Abbott, GenLab Developing Molecular Assay for Orthopedic Infections | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today announced a deal with Genetics Laboratory to develop and commercialize an assay for the detection of infections in bones and joints.

The assay will be developed for use on Abbott's Plex-ID automated platform for the identification of microbes. The platform is intended for non-diagnostic use only in the US, but assays are being developed for future clinical diagnostic purposes, Abbott said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.